Browsing Tag
essential thrombocythemia
3 posts
Myelofibrosis breakthrough? Incyte’s INCA033989 delivers clinical and molecular wins
Incyte’s mutCALR antibody shows promise in myelofibrosis and ET. Find out what ASH 2025 data reveals about INCA033989’s future potential.
Galecto pivots to oncology with Damora Therapeutics buyout and massive $285m funding boost
Discover how Galecto’s $285 M Damora Therapeutics acquisition and new mutCALR antibody pipeline could transform myelofibrosis and thrombocythemia treatment.
PharmaEssentia surpasses enrollment goals in clinical trials for hematology candidate BESREMi
PharmaEssentia USA Corporation, a key player in biopharmaceutical innovation and a subsidiary of Taiwan-based PharmaEssentia Corporation, has announced…